58 results on '"Mousa, Shaker A."'
Search Results
2. Abstract 16810: Identification of a New Class of Small Molecule Antagonists for Protease Proprotein Convertase Subtilisin-Like Kexin Type 9
3. Current status and future direction in the management of malignant melanoma
4. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery
5. Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk
6. Recent advances and future directions in the management of hepatitis C infections
7. Stem cells in the management of heart failure: what have we learned from clinical trials?
8. Genotype-guided use of oral antithrombotic therapy: a pharmacoeconomic perspective
9. Analysis of fine structure and biochemical changes of retina during aging of Wistar albino rats
10. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
11. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
12. Onyx® in the management of cranial arteriovenous malformations
13. Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions: Structure-Function Relationship
14. The Future of Anticoagulant Therapy
15. Metformin and neoplasia: Implications and indications
16. Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
17. Overlapping nongenomic and genomic actions of thyroid hormone and steroids
18. Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise
19. Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion
20. Human Platelet Aggregation and Degranulation Is Induced In Vitro by L-Thyroxine, but Not by 3,5,3′-Triiodo-L-Thyronine or Diiodothyropropionic Acid (DITPA)
21. Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration
22. Antiplatelet Therapy Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
23. Cancer Detection and Treatment: The Role of Nanomedicines
24. Heparin Anticoagulation Responsiveness in a Coronary Care Unit: A Prospective Observational Study
25. Hyaluronan- and heparin-reduced silver nanoparticles with antimicrobial properties
26. The multiple faces of nicotine and its implications in tissue and wound repair
27. Use of Recombinant Activated Factor VII to Arrest Uncontrolled Bleeding: A Case Series
28. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP)
29. Thyroid Hormone-Induced Angiogenesis
30. Resveratrol as a Supplemental Therapeutic in Cardiovascular and Metabolic Syndromes: A Critical Review
31. PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
32. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
33. Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway
34. The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand
35. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor
36. Cell Adhesion Molecules: Potential Therapeutic & Diagnostic Implications
37. Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects
38. The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis
39. From Nutraceuticals to Pharmaceuticals to Nanopharmaceuticals: A Case Study in Angiogenesis Modulation During Oxidative Stress
40. Heparin, Low Molecular Weight Heparin, and Derivatives in Thrombosis, Angiogenesis, and Inflammation: Emerging Links
41. Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds
42. Platelet GPIIb/IIIa Antagonist, XV459, in Heparin-Induced Thrombocytopenia
43. Proangiogenesis Action of the Thyroid Hormone Analog 3,5-Diiodothyropropionic Acid (DITPA) Is Initiated at the Cell Surface and Is Integrin Mediated
44. Generic Low Molecular Weight Heparins: A Significant Dilemma
45. Integrin αVβ3 Contains a Cell Surface Receptor Site for Thyroid Hormone that Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis
46. Low-Molecular-Weight Heparin in Thrombosis and Cancer
47. Antithrombotics in thrombosis and cancer
48. Pharmacodynamic Properties of the Low Molecular Weight Heparin, Tinzaparin: Effect of Molecular Weight Distribution on Plasma Tissue Factor Pathway Inhibitor in Healthy Human Subjects
49. Anticoagulants in thrombosis and cancer: the missing link
50. Anticoagulants in Thrombosis and Cancer: The Missing Link
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.